Abstract
Bursera schlechtendalii (Burseraceae) has shown antitumor activity against the 9KB (adenocarcinoma of nasal pharynx) test system. Two new lignans isolated from the biologically active plant fraction were identified as (—)‐trans‐2‐(3″,4″,5″‐trimethoxy‐benzyl)‐3‐(3′,4′‐methylenedioxybenzyl)butyrolactone and (—)‐trans ‐ 2 ‐ (3″,4″ ‐ dimethoxybenzyl) ‐ 3 ‐ (3′,4′ ‐ methylenedioxybenzyl)butyrolactone. In addition, the triterpene α‐amyrin was isolated from the active fraction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1992-1994 |
| Number of pages | 3 |
| Journal | Journal of pharmaceutical sciences |
| Volume | 61 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1972 |
Keywords
- Antitumor activity—isolation and structure determination of two lignans from Bursera schlechtendalii
- Bursera schlechtendalii (Burseraceae)—isolation and structure determination of two new lignans
- Lignans—isolated from Bursera schlechtendalii, structure determination
- α‐Amyrin—isolated from Bursera schlechtendalii
ASJC Scopus subject areas
- Pharmaceutical Science